244 related articles for article (PubMed ID: 15706444)
1. Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics.
de Mestier P; des Guetz G
World J Surg; 2005 Mar; 29(3):357-61; discussion 362. PubMed ID: 15706444
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202).
Nishida T; Shirao K; Sawaki A; Koseki M; Okamura T; Ohtsu A; Sugiyama T; Miyakawa K; Hirota S
Int J Clin Oncol; 2008 Jun; 13(3):244-51. PubMed ID: 18553235
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
5. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumor (GIST) and imatinib.
Kubota T
Int J Clin Oncol; 2006 Jun; 11(3):184-9. PubMed ID: 16850124
[TBL] [Abstract][Full Text] [Related]
7. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
Nishida T; Omori T; Ueshima S
Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
[TBL] [Abstract][Full Text] [Related]
8. [Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear].
Ahlman H; Nilsson O; Nilsson B
Lakartidningen; 2009 Dec 9-21; 106(50-51):3424-9. PubMed ID: 20180446
[No Abstract] [Full Text] [Related]
9. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
Mac K; Wójcik M
Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
[TBL] [Abstract][Full Text] [Related]
11. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic and predictive role of kit (CD117)].
Dirnhofer S; Zimpfer A; Went P
Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
[TBL] [Abstract][Full Text] [Related]
13. [Surgery on gastrountestinal stromal tumor CD117+ (G.I.S.T.): personal experience].
Cavallaro A; Lauretta A; Cavallaro M; Pennisi S; Cavallaro V
Ann Ital Chir; 2006; 77(2):137-41. PubMed ID: 17147087
[TBL] [Abstract][Full Text] [Related]
14. Advances in adjuvant therapy of gastrointestinal stromal tumors.
Adekola K; Agulnik M
Curr Oncol Rep; 2012 Aug; 14(4):327-32. PubMed ID: 22535506
[TBL] [Abstract][Full Text] [Related]
15. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate.
Okur A; Oguz A; Karadeniz C; Pinarli FG; Ozen O; Ekinci O
Tumori; 2012; 98(2):59e-62e. PubMed ID: 22678007
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of gastrointestinal stromal tumor.
D'Adamo D
Adv Ther; 2009 Sep; 26(9):826-37. PubMed ID: 19802531
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: diagnosis and treatment.
Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
[TBL] [Abstract][Full Text] [Related]
18. New strategies for treating GIST when imatinib fails.
Boyar MS; Taub RN
Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case.
Kobayashi M; Okamoto K; Nakatani H; Okabayashi T; Namikawa T; Ichikawa K; Kitagawa H; Araki K
Surg Today; 2006; 36(8):727-32. PubMed ID: 16865518
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors: a paradigm for therapeutic options in solid organ tumors.
Novak C; Trevino JG
Mini Rev Med Chem; 2010 Jun; 10(7):624-34. PubMed ID: 20500152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
